ECHOCARDIOGRAPHIC MYOCARDIAL CHANGES IN ACROMEGALY: A CROSS-SECTIONAL ANALYSIS IN A TERTIARY CENTER IN BULGARIA.
GH
IGF-1
acromegaly
acromegaly cardiomyopathy
echocardiography
Journal
Acta endocrinologica (Bucharest, Romania : 2005)
ISSN: 1841-0987
Titre abrégé: Acta Endocrinol (Buchar)
Pays: Romania
ID NLM: 101269720
Informations de publication
Date de publication:
Historique:
entrez:
1
6
2019
pubmed:
1
6
2019
medline:
1
6
2019
Statut:
ppublish
Résumé
Cardiomyopathy is the most frequent cardiovascular complication in acromegaly. We aimed to compare some echocardiographic markers in acromegaly patients with controls and find a correlation with disease duration, disease activity, levels of growth hormone (GH) and insulin-like growth factor 1 (IGF-1). We conducted a cross-sectional case-control study for the period of 2008-2012. Acromegaly patients altogether 146 (56 men and 90 women), were divided into four groups according to disease activity and the presence of arterial hypertension (AH). The control group included 83 subjects, matching the patient groups by age, gender and presence of AH. GH was measured by an immunofluorometric method, while IGF-1 by IRMA method. All patients and controls were subjected to one- and two-dimensional transthoracic echocardiography, color and pulse Doppler. We found a thickening of the left ventricular walls and an increase in the left ventricular mass. However, these changes were not statistically significant in all groups and no correlation with disease duration could be demonstrated. As markers of diastolic dysfunction, increased deceleration time and isovolumetric relaxation were registered, which were dependent mainly on age in a binary logistic regression analysis, but not GH or IGF-1. Using absolute values, ejection and shortening fractions were increased in some groups. Using cut-off values, a higher percentage of systolic dysfunction was demonstrated in patients compared to their corresponding controls. Engagement of the right heart ventricle was also found - increased deceleration time and decreased e/a tric ratio. In conclusion, functional impairments of both ventricles were present, with a predominance of left ventricular diastolic dysfunction.
Identifiants
pubmed: 31149060
doi: 10.4183/aeb.2019.52
pii: aeb.2019.52
pmc: PMC6535331
doi:
Types de publication
Journal Article
Langues
eng
Pagination
52-61Déclaration de conflit d'intérêts
The authors declare that they have no conflict of interest.
Références
Horm Metab Res. 1999 Feb-Mar;31(2-3):50-4
pubmed: 10226781
J Clin Endocrinol Metab. 1999 May;84(5):1518-23
pubmed: 10323372
J Clin Endocrinol Metab. 2000 Jan;85(1):193-9
pubmed: 10634386
Clin Endocrinol (Oxf). 2001 Feb;54(2):137-54
pubmed: 11207626
J Clin Endocrinol Metab. 2002 Jul;87(7):3097-104
pubmed: 12107207
J Clin Endocrinol Metab. 2002 Sep;87(9):4054-8
pubmed: 12213843
Clin Endocrinol (Oxf). 2003 Feb;58(2):169-76
pubmed: 12580932
Endocr Rev. 2003 Jun;24(3):272-7
pubmed: 12788799
J Clin Endocrinol Metab. 2004 Feb;89(2):667-74
pubmed: 14764779
Endocr Rev. 2004 Feb;25(1):102-52
pubmed: 14769829
N Engl J Med. 2006 Dec 14;355(24):2558-73
pubmed: 17167139
Clin Endocrinol (Oxf). 2008 Mar;68(3):361-8
pubmed: 17854389
J Clin Endocrinol Metab. 2008 Jul;93(7):2639-46
pubmed: 18445662
Eur J Endocrinol. 2008 Aug;159(2):89-95
pubmed: 18524797
J Clin Endocrinol Metab. 2009 May;94(5):1509-17
pubmed: 19208732
Acta Diabetol. 2009 Jun;46(2):85-95
pubmed: 19322513
Am J Cardiol. 1991 Feb 1;67(4):269-73
pubmed: 1990791
Clin Endocrinol (Oxf). 2011 Aug;75(2):220-5
pubmed: 21521288
Eur J Endocrinol. 2011 Nov;165(5):713-21
pubmed: 21868601
Ann Intern Med. 1990 Dec 15;113(12):921-5
pubmed: 2240917
Clin Endocrinol (Oxf). 2013 Jan;78(1):94-101
pubmed: 22702655
J Clin Endocrinol Metab. 2014 Dec;99(12):4438-46
pubmed: 25210882
Int J Endocrinol. 2015;2015:573643
pubmed: 26600803
Endocr Relat Cancer. 2015 Jun;23(6):469-80
pubmed: 27185871
Hypertension. 1987 Feb;9(2 Pt 2):II19-26
pubmed: 2948914
Q J Med. 1987 Jan;62(237):41-58
pubmed: 2962220
Int J Endocrinol. 2018 Jul 11;2018:6935054
pubmed: 30123265
Acta Endocrinol (Buchar). 2018 Jul-Sep;14(3):365-374
pubmed: 31149285
Acta Cardiol. 1987;42(1):1-10
pubmed: 3494364
Ann Intern Med. 1974 Jul;81(1):11-8
pubmed: 4276173
Q J Med. 1970 Jan;39(153):1-16
pubmed: 5427331
Endocr Rev. 1984 Spring;5(2):356-69
pubmed: 6376081
Am Heart J. 1980 Jul;100(1):41-52
pubmed: 6446234
Circulation. 1993 May;87(5):1715-21
pubmed: 7683979
Am J Cardiol. 1995 May 15;75(15):1042-7
pubmed: 7747686
J Am Coll Cardiol. 1995 Mar 15;25(4):879-84
pubmed: 7884091
J Clin Endocrinol Metab. 1994 Aug;79(2):441-6
pubmed: 8045960
Circ Res. 1993 Jan;72(1):57-64
pubmed: 8417847
Eur Heart J. 1993 Jan;14(1):26-33
pubmed: 8432287
Hypertension. 1998 Aug;32(2):228-34
pubmed: 9719047
Clin Endocrinol (Oxf). 1998 Jul;49(1):101-6
pubmed: 9797853